Ftse Mib
35.402,26
-0,02%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.820,64
2,42%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ InMed Pharmaceuticals Inc (INM) InMed Pharmaceuticals Inc (INM) Notizie

INM

InMed Pharmaceuticals (INM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INM
DataOraFonteTitoloSimboloCompagnia
14/05/202422:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INMInMed Pharmaceuticals Inc
05/03/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
27/02/202421:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INMInMed Pharmaceuticals Inc
13/02/202423:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INMInMed Pharmaceuticals Inc
21/12/202323:21Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:INMInMed Pharmaceuticals Inc
14/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INMInMed Pharmaceuticals Inc
13/11/202323:05Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:INMInMed Pharmaceuticals Inc
08/11/202323:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:INMInMed Pharmaceuticals Inc
27/10/202322:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INMInMed Pharmaceuticals Inc
27/10/202322:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:INMInMed Pharmaceuticals Inc
29/09/202317:43Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INMInMed Pharmaceuticals Inc
29/09/202317:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:INMInMed Pharmaceuticals Inc
25/05/202318:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INMInMed Pharmaceuticals Inc
17/05/202300:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INMInMed Pharmaceuticals Inc
15/05/202317:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INMInMed Pharmaceuticals Inc
10/03/202314:35GlobeNewswire Inc.Life Sciences Virtual Investor Forum: Presentations Now Available for Online ViewingNASDAQ:INMInMed Pharmaceuticals Inc
07/03/202314:35GlobeNewswire Inc.Life Sciences Virtual Investor Forum Agenda Announced for March 9thNASDAQ:INMInMed Pharmaceuticals Inc
20/02/202317:00GlobeNewswire Inc.InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business UpdateNASDAQ:INMInMed Pharmaceuticals Inc
14/02/202318:59Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:INMInMed Pharmaceuticals Inc
10/02/202312:09Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:INMInMed Pharmaceuticals Inc
10/02/202303:40GlobeNewswire Inc.InMed Submits Form 12b-25NASDAQ:INMInMed Pharmaceuticals Inc
10/01/202313:30GlobeNewswire Inc.InMed Provides Business Update and Milestones for 2023NASDAQ:INMInMed Pharmaceuticals Inc
16/12/202200:17GlobeNewswire Inc.InMed Announces Results of 2022 Annual General MeetingNASDAQ:INMInMed Pharmaceuticals Inc
15/12/202217:44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:INMInMed Pharmaceuticals Inc
15/12/202212:43Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INMInMed Pharmaceuticals Inc
13/12/202200:47GlobeNewswire Inc.InMed Announces Appointment of Interim Chief Financial Officer and Change of AuditorNASDAQ:INMInMed Pharmaceuticals Inc
07/12/202222:37Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:INMInMed Pharmaceuticals Inc
06/12/202212:02Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:INMInMed Pharmaceuticals Inc
21/11/202223:00GlobeNewswire Inc.InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to MarketNASDAQ:INMInMed Pharmaceuticals Inc
18/11/202214:00GlobeNewswire Inc.InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to MarketNASDAQ:INMInMed Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:INM

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BAMI
Banco BPM
BIT
SPM
Saipem
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
CPR
Davide Campari
BIT
G
Generali
BIT
TIT
Telecom Italia
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network